$0.10
0.00 (-0.21%)

Key Metrics

Market Cap
$95.35M
P/E Ratio
-1.62
EPS
$-0.06
Beta
N/A
Dividend Yield
N/A
ROE
-51.86%
Current Ratio
8.44

Company Information

Industry
Drug Manufacturers Specialty Generic

About Zomedica Corp

Zomedica Corp a veterinary health company focuses on the unmet needs of clinical veterinarians by developing products for companion animals The company engages in the development and commercialization of TRUFORMA platform which offers pointofcare diagnostic products for disease states in dogs and cats and PulseVet provides for treatment of various musculoskeletal issues such as broken bones tendonitis and torn ligaments in horses and small animals It has collaboration agreements with Celsee Inc for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals and Seraph Biosciences Inc for development and markets a novel pathogen detection system The company was formerly known as Zomedica Pharmaceuticals Corp and changed its name to Zomedica Corp in October 2020 Zomedica Corp was founded in 2015 and is headquartered in Ann Arbor Michigan

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-03-13 $-0.01 $-0.01 +0.0%
2023-03-15 $-0.01 $-0.01 40.1%
2020-08-10 $-0.02 $-0.01 100.0%
2020-05-11 $-0.02 $-0.02 +0.0%

Financial Ratios (TTM)

Gross Margin
76.38%
Operating Margin
-310.99%
Net Margin
-300.11%
ROA
-62.36%
Price to Book
0.76
Price to Sales
3.36